Table 2.

Change from baseline.

Variable	n	Change	95% CI	p-Value
IPSS
1 month	6	−10.2	[−23.1; 2.8]	0.10
6 months	6	−11.3	[−24.1; 1.5]	0.07
IPSS-QoL
1 month	6	−3.5	[−5.1; −1.9]	<0.01
6 months	6	−4.5	[−5.6; −3.4]	<0.01
IIEF-5
1 month	2	3.5	[−91.8; 98.8]	0.72
6 months	2	5.5	[−64.4; 75.4]	0.50
PVR, mL
1 month	4	16.2	[−84.6; 117.1]	0.64
6 months	2	7	[−5.7; 19.7]	0.09
PSA, µg/L
24-h	10	119.8	[41.0; 198.7]	<0.01
1 month	11	−2.5	[−7.6; 2.6]	0.30
6 months	11	−4.6	[−9.2; 0.0]	0.051
PV, cm3
1 month	10	−17	[−31.3; −2.7]	0.03
6 months	10	−26.6	[−50.9; −2.3]	0.04
Qmax, mL/s
1 month	3	3.8	[−5.7; 13.2]	0.23
6 months	2	0.4	[−5.3;6.2]	0.50

CI, confidence interval; IPSS, international prostate symptom score; IPSS-QoL, quality of life; IIEF-5, international index of erectile function; PVR, post-void residual; PSA, prostate-specific antigen; PV, prostate volume; Q_max, peak urinary flow rate.